Saluda Medical is a global medical device company focused on developing evoked compound action potential (ECAP) devices such as Evoke for the neuromodulation industry. It measures the spinal cord’s response to stimulation, adjusts on every pulse to optimize activation within the patient’s therapeutic window, and maintains long-term results through ECAP control.
|Employees (est.) (Oct 2021)||209||(-2%)|
Saluda Medical total Funding
Saluda Medical latest funding size
Time since last funding
|2 years ago|
Saluda Medical investors
|Medtronic, Redmile Group, Boston Scientific, BioScience Managers Limited, Action Potential Venture Capital|
Saluda Medical has 264 Twitter Followers. The number of followers has increased 2.9% month over month and increased 5.1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Saluda Medical founded?
Saluda Medical was founded in 2011.
Who are Saluda Medical key executives?
Saluda Medical's key executives are John Parker, Chris Beare and Greg Plamondon.
How many employees does Saluda Medical have?
Saluda Medical has 209 employees.
Who are Saluda Medical competitors?
Competitors of Saluda Medical include Nevro Corp., Terumo Aortic and Breas Medical.
Where is Saluda Medical headquarters?
Saluda Medical headquarters is located at Ground Floor, 407 Pacific Hwy, Artarmon.
Where are Saluda Medical offices?
Saluda Medical has offices in Artarmon, Minneapolis and Harrogate.
How many offices does Saluda Medical have?
Saluda Medical has 3 offices.
Receive alerts for 300+ data fields across thousands of companies